Clinical Efficacy of Buzhong Yiqi Decoction in Patients with Gastric Cancer Chemotherapy and Its Mechanism of Regulating Immunity

Jiangsu Provincial Hospital of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Histologically or cytologically confirmed gastric cancer;
•2. TCM syndrome type belongs to spleen and stomach qi deficiency;
•3. Aged 18-80 years, physical condition is good, ECOG <= 2 points;
•4. Expected survival time is more than 3 months;
•5. It meets the indications and basic requirements of chemotherapy, including: the peripheral blood image is basically normal, the functions of the heart, liver, kidney and other important organs are not obviously abnormal, the electrocardiogram is basically normal, and there is no unhealed wound on the body;
•6. Volunteer to participate in the study, with good compliance, able to cooperate with experimental observation, and sign the written informed consent.

•1. Patients who cannot oral administration (including digestive tract obstruction, jejunostomy);;
•2. Patients who are allergic to experimental drugs;
•3. Patients with serious cardiovascular, liver, kidney and blood system diseases;
•4. Brain metastasis or suffering from a mentally ill person;
•5. Patients participating in other clinical trials;
•6. Patients with poor compliance.

发起方

Jiangsu Provincial Hospital of Traditional Chinese Medicine